本期 13F-HR 中的全部持仓，以及相对上季度的变化。
13F 持仓，最新季度
来源SEC EDGAR13F-HR
TRV GP II, LLC (CIK 1614073) reported $1.3M across 1 reported positions in its SEC 13F filing for 2022-09-30. Largest positions: JNCE ($1.3M, 100.00%), ALNAQ ($0, 0.00%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | JNCE | JOUNCE THERAPEUTICS, INC. | $1.3M | 100.00% | 572,829 | Trimmed |
| 2 | ALNAQ | ALLENA PHARMACEUTICALS, INC. | $0 | 0.00% | 0 | Exited |
来源：SEC 13F 申报文件 · 截至 2022-09-30